Although we did not find that KMT2D loss in HNSCC affected the expression of PER2 or IGFBP5, it is most likely that KMT2D mutation utilizes a similar mechanism to promote glycolytic gene expression. The gene discussed is IGFBP5; the disease is head and neck squamous cell carcinoma.